financetom
Business
financetom
/
Business
/
US port operators seek to mitigate hefty expected tariffs on China-built port cranes
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US port operators seek to mitigate hefty expected tariffs on China-built port cranes
Jul 11, 2025 11:48 AM

*

Trump administration signals it wants to stop purchases

of

China-made port cranes

*

Industry group executive sees 100% tariffs as "the floor"

*

Trump tariff push comes after Biden imposed 25% levies on

China

cranes

By Lisa Baertlein

LOS ANGELES, July 11 (Reuters) -

U.S. seaport operators are asking for extra time to

implement pending tariffs on towering ship-to-shore cranes as

they expect President Donald Trump's administration to follow

through on a promise to essentially ban that vital

cargo-handling equipment.

The United States Trade Representative (USTR) earlier this

year proposed tariffs of up to 100% on those cranes after China

devoured market share in its bid to dominate maritime

manufacturing as well as commercial and military dominance on

the seas.

China, via state-owned Shanghai Zhenhua Heavy Industries (ZMPC),

now commands the global market and has supplied some 80% of the

ship-to-shore cranes in the United States. ZPMC has more than

200 cranes in operation across nearly two dozen U.S. ports,

including Houston, Los Angeles and New York. Each of those

cranes costs anywhere from $10 million to $20 million.

Countering that trend is a priority for the Trump

administration, whose officials stated in meetings they intended

to put an end to such purchases, said Carl Bentzel, president of

the National Association of Waterfront Employers (NAWE), which

represents terminal operators and other groups.

Asked whether he expected the tariff rate to land at around

100% when USTR issues its pending decision on the matter,

Bentzel said, "I've been operating under the position that

that's the floor. This essentially is a ban on the use of

Chinese manufactured cargo equipment."

USTR and the White House did not immediately comment.

Trump is not the first U.S. President to push ports to buy

higher-priced cranes from manufacturers with ties to U.S.

allies, including Konecranes of Finland, Mitsui E&S ( MIESF )

of Japan and Swiss-headquartered Liebherr.

Joe Biden slapped 25% tariffs on ship-to-shore cranes from

China in 2024 after the Cybersecurity and Infrastructure

Security Agency, the Federal Bureau of Investigation and the

National Security Agency publicly stated that China has sought

to preposition cyber vulnerabilities in American critical

infrastructure, including port equipment.

U.S. officials also warned that modems, software and other

technology in that equipment could be a backdoor for spying on

military operations or used as kill switches to hobble port

operations.

Nevertheless, ports and terminal operators continued buying

lower-cost Chinese cranes.

"The inaction and resistance from the port operator

community is focused on short-term cost savings and massively

underestimates the ultimate cost of inaction," said William

Henagan, a Council on Foreign Relations research fellow who was

director for critical infrastructure at the National Security

Council under Biden.

U.S. port operators and representatives for ZMPC

in letters to USTR in May said security concerns

linked to the cranes were out of proportion to the risk.

Opponents also warned that the tariffs could heave billions of

dollars of unexpected costs on the industry, stifling

improvements meant to keep U.S. ports competitive.

These days NAWE, one of the industry organizations

representing terminal operators, is working to mitigate the

impact of the new tariffs by asking for exemptions for

previously ordered cranes and a transition period for the

implementation of new duties.

"We've chosen to work with them," Bentzel said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Golden Arrow Receives Environmental Approval For San Pietro Project, Chile
Golden Arrow Receives Environmental Approval For San Pietro Project, Chile
Nov 10, 2025
10:40 AM EST, 11/10/2025 (MT Newswires) -- Golden Arrow Resources ( GARWF ) Monday said it has been issued an Environmental Qualification Resolution by the Chilean government for the San Pietro Project. The RCA permits an additional 80 drilling platforms, mainly in the area of the Rincones and Colla deposits. Each platform is a location where one or more drill...
Loop Industries Enters Offtake Agreement With Nike to Supply Polyester Resin
Loop Industries Enters Offtake Agreement With Nike to Supply Polyester Resin
Nov 10, 2025
10:41 AM EST, 11/10/2025 (MT Newswires) -- Loop Industries ( LOOP ) said Monday that it has reached a multi-year offtake agreement with Nike ( NKE ) to supply its Twist polyester resin from its manufacturing facility in India. Loop said the offtake deal makes Nike ( NKE ) the anchor customer for its Infinite Loop India manufacturing facility, which...
P2 Gold Provides Gabbs Project Update; Shares up 13%
P2 Gold Provides Gabbs Project Update; Shares up 13%
Nov 10, 2025
10:43 AM EST, 11/10/2025 (MT Newswires) -- P2 Gold ( PGLDF ) earlier Monday provided an update on activities at its wholly-owned gold-copper Gabbs Project located on the Walker-Lane Trend in Nevada. The company said that a reverse circulation (RC) drill rig was mobilized to site on Oct 22, 2025, and expansion and infill drilling is underway. It added that,...
AnaptysBio's Rosnilimab Misses Endpoints in Phase 2 Ulcerative Colitis Study; Shares Fall
AnaptysBio's Rosnilimab Misses Endpoints in Phase 2 Ulcerative Colitis Study; Shares Fall
Nov 10, 2025
10:42 AM EST, 11/10/2025 (MT Newswires) -- AnaptysBio ( ANAB ) said Monday its phase 2 trial of rosnilimab in ulcerative colitis failed to meet its primary endpoint and key secondary goals. The placebo-controlled study evaluated rosnilimab in patients with moderate-to-severe ulcerative colitis, a chronic inflammatory disease of the colon. Data show that rosnilimab was safe and well tolerated; however,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved